Despite the fact that the Gulf War ended in 1991, research in the area continues to expand. A meeting was held at the Royal Society of Medicine to hear of new findings and debate the direction of future Gulf health research.
Gulf health research began in the early 1990s as a response to concerns about adverse health conditions arising in veterans returning from service in the Persian Gulf arena. Some veterans were anxious about their reproductive health infertility, adverse pregnancy outcomes and illnesses in their children. Others had psychiatric disorders including post-traumatic stress disorder, or unexplained symptoms including fatigue, musculoskeletal complaints and general malaise. After suggestions that these symptoms could form the basis of a new medical condition, 'Gulf War syndrome', hypotheses were generated as to what sort of exposures might be associated with particular adverse health outcomes.
A major difficulty with Gulf health research is the accurate measurement of health outcomes since the illnesses are hard to define. Many are self-reported symptoms, and this may lead to biased reporting: some veterans, possibly those reporting the most symptoms, may come forward while others do not. Many of the symptoms, such as pain and fatigue, are difficult to measure accurately because they are subjective. Although the war ended several years ago, many more years of follow-up will be needed to get an accurate picture of the incidence of diseases whose onset is slow, e.g. cancers.
What exposures have been proposed as possible causes of ill-health in Gulf war veterans? One of them is the vaccines against possible biological warfare (such as anthrax and plague) that the troops were given. Another is the chemical pyridostigmine bromide which was used as a prophylactic agent against nerve gas exposure (NAPS tablets). Possible exposure to Iraqi nerve gas agents and biological warfare agents, inadvertently blown up by US troops, and emissions from oil well fires and spills are being studied, as are contact with depleted uranium from handling explosives, the general experience of battle conditions, and the psychosocial stresses associated with deployment. The complex interactions between some of these exposures are being examined to see whether combinations of exposures affected health.
During the meeting Lieut. Col. Rick Riddle, Office of the Assistant Secretary of Defence for Health Affairs, highlighted the lack of information available on exposures. After personnel entered the Persian Gulf arena, no information was routinely recorded as to which vaccines they received or who took NAPS tablets and how often. Researchers now have to rely on the veterans' memory of what immunizations they received, which after so many years may be subject to recall bias. One way round this obstacle is to model the likelihood of veterans' exposure to environmental hazards, such as the toxins from oil well fires, from information on the geographical placement of a military unit at a particular time. However, this cannot tell us definitely whether they were exposed or not. Data on the long-term risks of certain exposures will emerge over the next few years.
Col. John Graham, British Liaison Officer (Gulf health) emphasized that, even if the illnesses of Gulf War veterans cannot be labelled, they must not be discounted. Throughout history, veterans have reported adverse health effects after being deployed to battle1. Professor Simon Wessely, of King's College, London, highlighted the value of historical enquiry into war syndromes in general. Many veterans of the First World War reported poor physical and mental health after returning from battle, and their medical records are only now becoming available. A primary concern of the Gulf health researchers is to ascertain whether the illnesses are related to a general exposure to war or to the specific exposures within the Persian Gulf arena. Separation of the two is complicated by the fact that many Gulf War veterans had been in previous confficts.
A large area of Gulf health research focuses on adverse reproductive outcomes. Dr Pat Doyle, of the London School of Hygiene and Tropical Medicine, and colleagues are undertaking a retrospective cohort study of all British armed forces personnel who served in the Gulf War. This cohort of approximately 53 000 service personnel will be compared with a cohort of armed forces personnel in service at the time of the Gulf War who were not deployed, matched for service, age, sex, rank and fitness. Dr Doyle emphasized the particular difficulty of measuring outcomes in reproductive health research (one of the indices being time taken to conceive, often poorly recorded). Dr Doyle will also look at the children of Gulf War veterans who have given informed consent, flagging them on UK national cancer and mortality databases. However, many years will During the meeting invited speakers from the USA described some important results that have already been published. Capt. Greg Gray, of the Naval Health Research Center, San Diego, presented research relating to symptom reporting and hospital admissions. In a large retrospective study comparing 547 076 Gulf War veterans with 618 338 era veterans not deployed to the Gulf, Gray et al. found that two years after the war there was no excess of hospital admissions in Gulf War veterans3. However, Gulf War veterans did report more symptoms than era controls. Capt. Gray doubted whether any single wartime exposure was responsible for the increase in symptoms, which was more likely to be due to the aggregate stressors of war. Similarly, Dr Drue Barrett and Dr William Reeves, from the Centers for Disease Control and Prevention, demonstrated that Gulf War veterans from Iowa and Air Force personnel from either Florida or Pennsylvania had reported a higher prevalence of a range of symptoms than nondeployed military personnel from those States. Both the Iowa study and the Air Force study pointed to lower daily health functioning in Gulf War veterans4.
Dr Frances Murphy spoke about the Department of Veterans' Affairs Gulf War Veterans Programme. Initiated in August 1992, it offers all Gulf War veterans a free health examination in which information is taken on exposures in the Persian Gulf arena. The most frequent symptoms for example, fatigue, rash, headache, musculoskeletal pain, sleep disturbances, cough-have been categorized broadly as connective tissue complaints, respiratory system complaints and mental disorders. So far, the symptoms reported by Gulf War veterans do not seem to localize in one organ and 26.5% of veterans enrolled in the programme have 'no medical diagnosis'. 12% of veterans reported no symptoms. Dr Murphy also commented on a study recording a small but significant excess risk of death in Gulf War veterans compared with veterans who did not serve in that war7, but these excess deaths were due to accidents rather than disease and seemed to be associated with an increase in risk-taking behaviour.
British researchers are also investigating symptom reporting in Gulf War veterans. The results of the King's College study have now been published, indicating that veterans reported an excess of health-related symptoms but yielding no evidence for a specific Gulf War illness8'9. Dr Gary MacFarlane explained the aims of a team at Manchester University who are recruiting a random sample of 4800 Gulf War veterans and 4800 matched military non-deployed veterans. All participants will be asked to complete a questionnaire on the type of symptoms experienced within the past month, and the Gulf War veterans will also be questioned on the exposures they encountered in the Persian Gulf arena. Most Gulf War health research is being done in the USA and the UK, but Canada, the Czech Republic and Denmark are amongst other countries investigating the issue. Dr Bernadette Guldager, of the University of Copenhagen, reported on the health of Danish veterans who had been deployed to participate in Operation Desert Peace in the aftermath of the war. Again, the Danish group found an excess prevalence of self-reported symptoms related to the central nervous system, psyche, skin and gastrointestinal system, but these were not associated with any specific exposure encountered in the Persian Gulf arena.
The meeting closed with a discussion session; and one large area of concern was that Gulf War veterans felt violated by the amount of research in which they were being asked to participate. Some investigators expressed the view that veterans were so keen to have a proper diagnosis that they would cheerfully take part in any research programme; others believed that veterans might accept a psychological explanation for their symptoms to avoid any further biological or physiological examinations.
Dr Tim Gerrity, from the US Department of Veterans Affairs, stated that between 1994 and 1998, US$115 million had been spent on US federally funded studies alone and he emphasized that Gulf War health research remains an area of great interest. One message from the conference was that, in future conflicts, the health of all service personnel needs to be recorded more carefully before and after deployment. Another was the importance of making accurate exposure measurements during a conflict.
